NM_138554.5:c.523A>G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_138554.5(TLR4):​c.523A>G​(p.Thr175Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000514 in 1,613,610 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.00049 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00052 ( 6 hom. )

Consequence

TLR4
NM_138554.5 missense

Scores

1
18

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: -0.0210

Publications

16 publications found
Variant links:
Genes affected
TLR4 (HGNC:11850): (toll like receptor 4) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. In silico studies have found a particularly strong binding of surface TLR4 with the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of Coronavirus disease-2019 (COVID-19). This receptor has also been implicated in signal transduction events induced by lipopolysaccharide (LPS) found in most gram-negative bacteria. Mutations in this gene have been associated with differences in LPS responsiveness, and with susceptibility to age-related macular degeneration. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0062856674).
BP6
Variant 9-117712651-A-G is Benign according to our data. Variant chr9-117712651-A-G is described in ClinVar as [Likely_benign]. Clinvar id is 3033547.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Homozygotes in GnomAdExome4 at 6 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TLR4NM_138554.5 linkc.523A>G p.Thr175Ala missense_variant Exon 3 of 3 ENST00000355622.8 NP_612564.1 O00206-1
TLR4NM_003266.4 linkc.403A>G p.Thr135Ala missense_variant Exon 4 of 4 NP_003257.1 O00206-2
TLR4NM_138557.3 linkc.-78A>G 5_prime_UTR_variant Exon 2 of 2 NP_612567.1 O00206-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TLR4ENST00000355622.8 linkc.523A>G p.Thr175Ala missense_variant Exon 3 of 3 1 NM_138554.5 ENSP00000363089.5 O00206-1
ENSG00000285082ENST00000697666.1 linkc.140+3922A>G intron_variant Intron 3 of 4 ENSP00000513391.1 A0A8V8TMK6

Frequencies

GnomAD3 genomes
AF:
0.000493
AC:
75
AN:
152130
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000328
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00482
Gnomad SAS
AF:
0.000831
Gnomad FIN
AF:
0.00245
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000191
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000651
AC:
163
AN:
250362
AF XY:
0.000665
show subpopulations
Gnomad AFR exome
AF:
0.0000620
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00310
Gnomad FIN exome
AF:
0.00301
Gnomad NFE exome
AF:
0.000177
Gnomad OTH exome
AF:
0.00115
GnomAD4 exome
AF:
0.000517
AC:
755
AN:
1461362
Hom.:
6
Cov.:
32
AF XY:
0.000515
AC XY:
374
AN XY:
726872
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33474
American (AMR)
AF:
0.0000224
AC:
1
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.0104
AC:
411
AN:
39686
South Asian (SAS)
AF:
0.000373
AC:
32
AN:
85844
European-Finnish (FIN)
AF:
0.00260
AC:
139
AN:
53402
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.000128
AC:
142
AN:
1111972
Other (OTH)
AF:
0.000447
AC:
27
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
51
102
152
203
254
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000493
AC:
75
AN:
152248
Hom.:
1
Cov.:
32
AF XY:
0.000551
AC XY:
41
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41568
American (AMR)
AF:
0.000327
AC:
5
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00484
AC:
25
AN:
5170
South Asian (SAS)
AF:
0.000832
AC:
4
AN:
4808
European-Finnish (FIN)
AF:
0.00245
AC:
26
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000191
AC:
13
AN:
68014
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000439
Hom.:
0
Bravo
AF:
0.000276
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000577
AC:
70
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

TLR4-related disorder Benign:1
Jun 08, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.66
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
0.15
DANN
Benign
0.58
DEOGEN2
Benign
0.12
.;T;T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.063
N
LIST_S2
Uncertain
0.90
D;.;D
M_CAP
Benign
0.0047
T
MetaRNN
Benign
0.0063
T;T;T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
1.2
.;L;L
PhyloP100
-0.021
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.95
N;.;N
REVEL
Benign
0.042
Sift
Benign
0.16
T;.;T
Sift4G
Benign
0.26
T;.;T
Polyphen
0.019
.;B;B
Vest4
0.082
MVP
0.28
MPC
0.089
ClinPred
0.014
T
GERP RS
-7.9
Varity_R
0.090
gMVP
0.12
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16906079; hg19: chr9-120474929; COSMIC: COSV105915035; API